CelLBxHealth plc Stock
Stocks
CLBX
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.406 GBX | -4.71% |
|
-7.84% | +27.77% |
| 07-07 | CelLBxHealth chief executive Collins to step down | AN |
| 07-07 | Cellbxhealth plc Announces Resignation of Peter Collins as Chief Executive Officer | CI |
| Market Cap | 16.76M 22.42M 19.62M 18.08M 31.82M 2.13B 32.33M 217M 84.33M 1.05B 84.18M 82.36M 3.63B | P/E 2025 * |
-0.26x | P/E 2026 * | -0.63x |
|---|---|---|---|---|---|
| Enterprise Value | 9.46M 12.66M 11.08M 10.21M 17.96M 1.2B 18.25M 122M 47.6M 593M 47.52M 46.49M 2.05B | EV / Sales 2025 * |
0.91x | EV / Sales 2026 * | 0.7x |
| Free-Float |
94.31% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: CelLBxHealth plc
| 16/10/25 | Angle names Peter Collins as interim CEO | AN |
| 28/05/25 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 23/01/25 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 14/09/23 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 24/01/22 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 day | -4.71% | ||
| 1 week | -7.84% | ||
| Current month | -7.84% | ||
| 1 month | -18.52% | ||
| 3 months | +56.17% | ||
| 6 months | +33.86% | ||
| Current year | +27.77% |
| 1 week | 1.41 | 1.67 | |
| 1 month | 1.3 | 2 | |
| Current year | 0.85 | 2.8 | |
| 1 year | 0.85 | 8 | |
| 3 years | 0.85 | 37.4 | |
| 5 years | 0.85 | 163.75 | |
| 10 years | 0.85 | 163.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 01/01/1999 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2025 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 22/05/2023 |
Klaas de Boer
BRD | Director/Board Member | 61 | 12/01/2026 |
| Director/Board Member | 61 | 12/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-19 | Buy | Chief Financial Officer | 2,500,000 | 0.7749% | ||
| 12-19 | Buy | Chairman | 5,000,000 | 1.5497% | ||
| 12-19 | Buy | Chief Executive Officer | 5,000,000 | 1.5497% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.71% | -7.84% | -78.38% | -87.51% | 22.42M | ||
| -3.23% | -2.18% | +3.60% | -27.41% | 16.54B | ||
| -3.35% | +9.52% | +35.27% | +90.40% | 1.65B | ||
| -5.53% | -11.00% | -47.50% | -80.98% | 1.16B | ||
| -0.36% | +0.13% | -31.02% | +31.73% | 1.1B | ||
| -4.07% | -2.54% | -28.53% | -54.68% | 613M | ||
| -3.14% | -7.46% | -39.94% | -57.41% | 550M | ||
| +0.52% | +0.47% | +27.28% | -53.71% | 449M | ||
| -1.11% | +1.80% | -55.00% | -59.62% | 382M | ||
| -3.07% | -2.20% | -26.41% | -29.89% | 337M | ||
| Average | -2.78% | -0.79% | -24.06% | -32.91% | 2.28B | |
| Weighted average by Cap. | -3.11% | +0.38% | -1.33% | -21.37% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.35M 13.85M 12.12M 11.17M 19.66M 1.31B 19.97M 134M 52.09M 649M 52M 50.88M 2.24B | 21.65M 28.96M 25.35M 23.36M 41.1M 2.75B 41.76M 280M 109M 1.36B 109M 106M 4.69B |
| Net income | -16.35M -21.87M -19.14M -17.64M -31.04M -2.08B -31.54M -212M -82.26M -1.02B -82.12M -80.34M -3.54B | -8.55M -11.44M -10.01M -9.22M -16.23M -1.09B -16.49M -111M -43.01M -536M -42.94M -42.01M -1.85B |
| Net Debt | -7.3M -9.77M -8.55M -7.88M -13.86M -927M -14.08M -94.44M -36.73M -457M -36.66M -35.87M -1.58B | -1.6M -2.14M -1.87M -1.73M -3.04M -203M -3.09M -20.7M -8.05M -100M -8.04M -7.86M -347M |
Employees
119
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | GBX 1.406 | -4.71% | 2,155,742 |
| 07/07/26 | GBX 1.475 | -7.81% | 4,128,376 |
| 06/07/26 | GBX 1.600 | +6.67% | 2,912,628 |
| 03/07/26 | GBX 1.500 | 0.00% | 716,727 |
| 02/07/26 | GBX 1.500 | -1.64% | 973,749 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0148GBP
Average target price
0.0400GBP
Spread / Average Target
+171.19%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
Select your edition
All financial news and data tailored to specific country editions

















